Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Comparative effectiveness of anti-growth factor therapies for diabetic macular edema: summary of primary findings and conclusions.

O'Malley PG.

Arch Intern Med. 2012 Jul 9;172(13):1014-5. doi: 10.1001/archinternmed.2012.2335. Review. No abstract available.

PMID:
22688778
2.

Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.

Jampol LM, Glassman AR, Bressler NM.

JAMA Ophthalmol. 2015 Sep;133(9):983-4. doi: 10.1001/jamaophthalmol.2015.1880. No abstract available.

PMID:
26087135
3.

Comparative effectiveness of anti-VEGF agents for diabetic macular edema.

Ollendorf DA, Colby JA, Pearson SD.

Int J Technol Assess Health Care. 2013 Oct;29(4):392-401. doi: 10.1017/S0266462313000500. Review.

PMID:
24290332
4.

[Anti-VEGF therapy to treat diabetic macular edema].

Takamura Y.

Nippon Ganka Gakkai Zasshi. 2014 Sep;118(9):747-9. Japanese. No abstract available.

PMID:
25318182
5.

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.

Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA 3rd; American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel..

JAMA Ophthalmol. 2016 Jan;134(1):95-9. doi: 10.1001/jamaophthalmol.2015.4110.

PMID:
26512939
6.

Anti-VEGF therapeutic approaches for diabetic macular edema.

Khurana RN, Do DV, Nguyen QD.

Int Ophthalmol Clin. 2009 Spring;49(2):109-19. doi: 10.1097/IIO.0b013e31819fd8b5. No abstract available.

PMID:
19349791
7.

Diabetic macular edema.

Lang GE.

Ophthalmologica. 2012;227 Suppl 1:21-9. doi: 10.1159/000337156. Review.

PMID:
22517122
8.

Anti-vascular endothelial growth factor for diabetic macular oedema.

Virgili G, Parravano M, Menchini F, Evans JR.

Cochrane Database Syst Rev. 2014 Oct 24;(10):CD007419. doi: 10.1002/14651858.CD007419.pub4. Review.

PMID:
25342124
9.

Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.

Chong V.

Ophthalmologica. 2012;227 Suppl 1:2-10. doi: 10.1159/000337152. Review.

PMID:
22517120
10.

Evidence for anti-VEGF treatment of diabetic macular edema.

Bandello F, Berchicci L, La Spina C, Battaglia Parodi M, Iacono P.

Ophthalmic Res. 2012;48 Suppl 1:16-20. doi: 10.1159/000339843. Review.

PMID:
22907145
11.

Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.

Wykoff CC, Hariprasad SM.

Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):302-5. doi: 10.3928/23258160-20150304-01. No abstract available.

PMID:
25835307
12.

Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.

Zhou S, Gao J, Xu X.

Clin Exp Ophthalmol. 2014 Sep-Oct;42(7):637-49. doi: 10.1111/ceo.12286.

PMID:
24330277
13.

Drugs for macular degeneration, price discrimination, and Medicare’s responsibility not to overpay.

Silver J.

JAMA. 2014 Jul 2;312(1):23-4. No abstract available. Erratum in: JAMA. 2014 Nov 19;312(19):2045.

PMID:
24860863
14.

[From scientific evidence to clinical practice: treatment protocols for diabetic macular edema].

López-Gálvez MI, García-Campos JM.

Arch Soc Esp Oftalmol. 2012 Dec;87 Suppl 1:38-45. Review. Spanish.

PMID:
24278988
15.
16.
17.

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.

Virgili G, Parravano M, Menchini F, Brunetti M.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007419. doi: 10.1002/14651858.CD007419.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD007419.

PMID:
23235642
18.

Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.

Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, Recchia FM.

Ophthalmology. 2012 Oct;119(10):2179-88. doi: 10.1016/j.ophtha.2012.07.058. Review.

PMID:
22917890
19.

Current intravitreal pharmacologic therapies for diabetic macular edema.

Colucciello M.

Postgrad Med. 2015 Aug;127(6):640-53. doi: 10.1080/00325481.2015.1052523. Review.

PMID:
26036708
20.

DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema.

Wykoff CC, Hariprasad SM.

Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 1;47(4):308-12. doi: 10.3928/23258160-20160324-01. No abstract available.

PMID:
27065368
Items per page

Supplemental Content

Support Center